3.42
Neuronetics Inc 주식(STIM)의 최신 뉴스
Neuronetics to join Russell 3000 and Russell 2000 indexes - MSN
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program - MarketScreener
Neuronetics (STIM) Showcases Innovations in Mental Health Care | - GuruFocus
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS - GuruFocus
Neuronetics (STIM) Showcases Innovations in Mental Health Care | STIM Stock News - GuruFocus
Neuronetics to Present New Research on TMS Therapy at 13th Annual Clinical TMS Society Meeting - Nasdaq
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program - The Manila Times
NeuroStar's Groundbreaking Study Shows How Its Depression Treatment Compares to Rival Brainsway: Key Findings - Stock Titan
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility - MSN
Neuronetics set to join Russell indexes in June By Investing.com - Investing.com South Africa
Neuronetics set to join Russell indexes in June - Investing.com India
Neuronetics (STIM) to Join Russell 3000 and Russell 2000 Indexes - GuruFocus
Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes - marketscreener.com
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes - GuruFocus
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes | STIM Stock News - GuruFocus
Neuronetics, Inc. to Join Russell 3000® and Russell 2000® Indexes Effective June 30, 2025 - Nasdaq
Major Milestone: Neuronetics Joins Russell 2000 and 3000 Indexes, Tapping Into $10.6T Benchmark Market - Stock Titan
Transcranial Magnetic Stimulator Market Future Business - openPR.com
Neuronetics reports annual meeting results By Investing.com - Investing.com Canada
Neuronetics reports annual meeting results - Investing.com Australia
Neuronetics Holds Annual Meeting, Elects Directors - TipRanks
Transcranial Magnetic Stimulators (TMS) Market to Set - openPR.com
Neuronetics' SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com UK
Neuronetics’ SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com Canada
Neuronetics’ SWOT analysis: stock outlook brightens post-merger - Investing.com
Neuronetics Posts Strong Revenue Growth in Q1 2025 - MSN
Insider Sell: Stephen Furlong Sells 200,000 Shares of Neuronetics Inc (STIM) - GuruFocus
Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All - simplywall.st
Neuronetics (STIM) Introduces Annual TMS Therapy Awareness Day | - GuruFocus
Neuronetics Launches First Inaugural National TMS Therapy Awaren - GuruFocus
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month - The Manila Times
Neuronetics Announces Inducement Awards for New Team Members - MSN
Q2 Earnings Forecast for Neuronetics Issued By William Blair - Defense World
Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83 - Yahoo
Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22% - Investing.com Nigeria
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges - Yahoo Finance
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges By GuruFocus - Investing.com Canada
Neuronetics Reports Strong Q1 2025 Growth - TipRanks
Neuronetics: Q1 Earnings Snapshot - CTPost
Neuronetics Q1 2025 Earnings Call Transcript - MarketBeat
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025 - marketscreener.com
Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth - Investing.com Canada
자본화:
|
볼륨(24시간):